{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:42:39Z","timestamp":1792618959700,"version":"4.5.0"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:p>OBJECTIVE. The objective of this study was to identify risk factors for developing chronic idiopathic thrombocytopenic purpura in a cohort of pediatric patients with idiopathic thrombocytopenic purpura.<\/jats:p>\n                  <jats:p>METHODS. We conducted a retrospective cohort analysis of 259 children who were diagnosed with idiopathic thrombocytopenic purpura between 1991 and 2000 at 1 of 8 managed care organizations that comprise the Vaccine Safety Datalink. We reviewed the charts of 595 potential patients with idiopathic thrombocytopenic purpura from the 8 Vaccine Safety Datalink sites and excluded patients with known causes of thrombocytopenia. Chronic idiopathic thrombocytopenic purpura was defined as having thrombocytopenia for 6 months beyond the initial diagnosis. The risk for developing chronic idiopathic thrombocytopenic purpura was assessed using simple and multivariable analyses.<\/jats:p>\n                  <jats:p>RESULTS. Of the 259 cases of idiopathic thrombocytopenic purpura, 197 (76%) were acute, 60 (23%) were chronic, and 2 (1%) could not be determined. Among the acute cases, the mean duration of illness was 22 days. There was 1 serious bleeding outcome in the cohort. In multivariable regression analysis, the patients with chronic illness were older, less likely to present with mucosal bleeding, less likely to have had an acute illness before diagnosis, and more likely to present with a platelet count &amp;gt;20000\/\u03bcL than children with acute idiopathic thrombocytopenic purpura. In particular, children whose illness was diagnosed at \u226510 years of age and who had platelet counts \u226520000\/\u03bcL had an approximate fivefold risk for progressing to chronic disease when compared with children who presented at \u22642 years of age with platelet counts &amp;lt;20000\/\u03bcL.<\/jats:p>\n                  <jats:p>CONCLUSIONS. Although idiopathic thrombocytopenic purpura tends to be a benign and self-limited condition, acute and chronic idiopathic thrombocytopenic purpura seem to be distinct illnesses defined by age, platelet count, bleeding symptoms, and the presence of acute illness before diagnosis. Physicians should be aware of these differences when advising their patients and families.<\/jats:p>","DOI":"10.1542\/peds.2007-1129","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T09:48:09Z","timestamp":1204278489000},"page":"e506-e512","source":"Crossref","is-referenced-by-count":75,"title":["A Population-Based, Multisite Cohort Study of the Predictors of Chronic Idiopathic Thrombocytopenic Purpura in Children"],"prefix":"10.1542","volume":"121","author":[{"given":"Jason","family":"Glanz","sequence":"first","affiliation":[{"name":"Institute for Health Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"France","sequence":"additional","affiliation":[{"name":"Institute for Health Research"},{"name":"Department of Preventive Medicine, Kaiser Permanente Colorado, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Xu","sequence":"additional","affiliation":[{"name":"Institute for Health Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hambidge","sequence":"additional","affiliation":[{"name":"Institute for Health Research"},{"name":"Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado"},{"name":"Community Health Services, Denver Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,3,1]]},"reference":[{"key":"2021120905475569200_R1","doi-asserted-by":"crossref","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med.2002;346(13):995\u20131008","DOI":"10.1056\/NEJMra010501"},{"key":"2021120905475569200_R2","doi-asserted-by":"crossref","unstructured":"Chu YW, Korb J, Sakamoto KM. Idiopathic thrombocytopenic purpura. Pediatr Rev.2000;21(3):95\u2013104","DOI":"10.1542\/pir.21-3-95"},{"key":"2021120905475569200_R3","doi-asserted-by":"crossref","unstructured":"Lilleyman JS. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol.1999;105(4):871\u2013875","DOI":"10.1111\/j.1365-2141.1999.01409.x"},{"key":"2021120905475569200_R4","doi-asserted-by":"crossref","unstructured":"Zeller B, Helgestad J, Hellebostad M, Kolmannskog S, Nystad T, Stensvold K. Immune thrombocytopenia in childhood in Norway: a prospective, population-based registration. Pediatr Hematol Oncol.2000;17(7):551\u2013558","DOI":"10.1080\/08880010050122816"},{"key":"2021120905475569200_R5","doi-asserted-by":"crossref","unstructured":"Walker RW, Walker W. Idiopathic thrombocytopenia, initial illness and long term follow up. Arch Dis Child.1984;59(4):316\u2013322","DOI":"10.1136\/adc.59.4.316"},{"key":"2021120905475569200_R6","doi-asserted-by":"crossref","unstructured":"Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost.2001;27(3):253\u2013267","DOI":"10.1055\/s-2001-15255"},{"key":"2021120905475569200_R7","doi-asserted-by":"crossref","unstructured":"Ku\u0308hne T, Buchanan GR, Zimmerman S, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the intercontinental childhood ITP study group. J Pediatr.2003;143(5):605\u2013608","DOI":"10.1067\/S0022-3476(03)00535-3"},{"key":"2021120905475569200_R8","doi-asserted-by":"crossref","unstructured":"Ku\u0308hne T, Imbach P, Bolton-Maggs PH, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet.2001;358(9299):2122\u20132125","DOI":"10.1016\/S0140-6736(01)07219-1"},{"key":"2021120905475569200_R9","doi-asserted-by":"crossref","unstructured":"Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child.1994;71(3):251\u2013253","DOI":"10.1136\/adc.71.3.251"},{"key":"2021120905475569200_R10","doi-asserted-by":"crossref","unstructured":"Zeller B, Rajantie J, Hedlund-Treutiger I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr.2005;94(2):178\u2013184","DOI":"10.1080\/08035250410025294"},{"key":"2021120905475569200_R11","doi-asserted-by":"crossref","unstructured":"Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history at the Childrens Hospital of Alabama. Clin Pediatr (Phila).2004;43(8):691\u2013702","DOI":"10.1177\/000992280404300802"},{"key":"2021120905475569200_R12","doi-asserted-by":"crossref","unstructured":"Rosth\u00f8j S, Hedlund-Treutiger I, Rajantie J, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr.2003;143(3):302\u2013307","DOI":"10.1067\/S0022-3476(03)00245-2"},{"key":"2021120905475569200_R13","doi-asserted-by":"crossref","unstructured":"Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second year of life. J Pediatr.2002;141(2):253\u2013258","DOI":"10.1067\/mpd.2002.125909"},{"key":"2021120905475569200_R14","doi-asserted-by":"crossref","unstructured":"Robb LG, Tiedman K. Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Child.1990;65(5):502\u2013506","DOI":"10.1136\/adc.65.5.502"},{"key":"2021120905475569200_R15","doi-asserted-by":"crossref","unstructured":"Reid, MM. Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome. Arch Dis Child.1995;72(2):125\u2013128","DOI":"10.1136\/adc.72.2.125"},{"key":"2021120905475569200_R16","doi-asserted-by":"crossref","unstructured":"Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopenic purpura. Br J Clin Pharmacol.2003;55(1):107\u2013111","DOI":"10.1046\/j.1365-2125.2003.01790.x"},{"key":"2021120905475569200_R17","doi-asserted-by":"crossref","unstructured":"Miller E, Waight P, Farrington P, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child.2001;84(3):227\u2013229","DOI":"10.1136\/adc.84.3.227"},{"key":"2021120905475569200_R18","doi-asserted-by":"crossref","unstructured":"France EK, Glanz J, Xu S, et al. The risk of idiopathic thrombocytopenia following measles-mumps-rubella immunization in children. Pediatrics.2008;121(3). Available at: www.pediatrics.org\/cgi\/content\/full\/121\/3\/e41","DOI":"10.1542\/peds.2007-1578"},{"key":"2021120905475569200_R19","doi-asserted-by":"crossref","unstructured":"Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics.1997;99(6):765\u2013773","DOI":"10.1542\/peds.99.6.765"},{"key":"2021120905475569200_R20","unstructured":"Allison P. Survival Analysis Using the SAS System. Cary, NC: SAS Institute;1996"},{"key":"2021120905475569200_R21","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet.1997;350(9078):620\u2013623","DOI":"10.1016\/S0140-6736(97)04143-3"},{"key":"2021120905475569200_R22","doi-asserted-by":"crossref","unstructured":"George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood.1996;88(1):3\u201340","DOI":"10.1182\/blood.V88.1.3.3"},{"key":"2021120905475569200_R23","doi-asserted-by":"crossref","unstructured":"Ku\u0308hne T. Idiopathic thrombocytopenic purpura in childhood: controversies and solutions. Pediatr Blood Cancer.2006;47(5 suppl):650\u2013652","DOI":"10.1002\/pbc.20973"},{"key":"2021120905475569200_R24","doi-asserted-by":"crossref","unstructured":"Blanchette VS, Luke B, Andrew M, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy and no therapy in childhood acute immune thrombocytopenia purpura. J Pediatr.1993;123(6):989\u2013995","DOI":"10.1016\/S0022-3476(05)80400-7"},{"key":"2021120905475569200_R25","doi-asserted-by":"crossref","unstructured":"Blanchette V, Imbach P, Andrew M, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet.1994;344(8924):703\u2013707","DOI":"10.1016\/S0140-6736(94)92205-5"},{"key":"2021120905475569200_R26","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs P, Tarantino MD, Buchanan GR, Bussel JB, George JN; American Society of Pediatric Hematology\/Oncology. The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology\/Oncology. J Pediatr Hematol Oncol.2004;26(2):146\u2013151","DOI":"10.1097\/00043426-200402000-00020"},{"key":"2021120905475569200_R27","doi-asserted-by":"crossref","unstructured":"George JN. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. Curr Hematol Rep.2003;2(5):381\u2013387","DOI":"10.1038\/sj.thj.6200414"},{"key":"2021120905475569200_R28","doi-asserted-by":"crossref","unstructured":"Lilleyman JS. Medical nemesis and childhood ITP. Br J Haematol.2003;123(4):586\u2013589","DOI":"10.1046\/j.1365-2141.2003.04656.x"},{"key":"2021120905475569200_R29","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs PH, Dickerhoff R, Vora AJ. The nontreatment of childhood ITP (or \u201cthe art of medicine consists of amusing the patient until nature cures the disease\u201d). Semin Thromb Hemost.2001;27(3):269\u2013275","DOI":"10.1055\/s-2001-15256"},{"key":"2021120905475569200_R30","doi-asserted-by":"crossref","unstructured":"George JN. Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient?J Pediatr.2000;137(5):598\u2013600","DOI":"10.1067\/mpd.2000.111164"},{"key":"2021120905475569200_R31","doi-asserted-by":"crossref","unstructured":"Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child.2000;83(3):220\u2013222","DOI":"10.1136\/adc.83.3.220"},{"key":"2021120905475569200_R32","doi-asserted-by":"crossref","unstructured":"Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenia in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr.2000;137(5):629\u2013632","DOI":"10.1067\/mpd.2000.110123"},{"key":"2021120905475569200_R33","doi-asserted-by":"crossref","unstructured":"Buchanan GR. Thrombocytopenia during childhood: what a pediatrician needs to know. Pediatr Rev.2005;26(11):401\u2013409","DOI":"10.1542\/pir.26-11-401"},{"key":"2021120905475569200_R34","doi-asserted-by":"crossref","unstructured":"Imbach P, Kuhne T, Muller D, et al. Childhood ITP: 12 months of follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS). Pediatr Blood Cancer.2006;46(3):351\u2013356","DOI":"10.1002\/pbc.20453"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/e506\/1123113\/zpe0030800e506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/3\/e506\/1123113\/zpe0030800e506.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T18:36:49Z","timestamp":1639075009000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/3\/e506\/72803\/A-Population-Based-Multisite-Cohort-Study-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,3,1]]},"published-print":{"date-parts":[[2008,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-1129","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}